$265.10
1.19%
Nasdaq, Oct 01, 04:11 pm EDT. Closed.
ISIN
US12572Q1058
Symbol
CME

CME Group a Target price 2026 - Analyst rating & recommendation

CME Group a Classifications & Recommendation

Buy
52%
Hold
33%
Sell
14%

CME Group a Price Target

Target Price $291.21
Price $265.10
Potential
Number of Estimates 17
17 Analysts have issued a price target CME Group a 2027 . The average CME Group a target price is $291.21. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 21 analysts: 11 Analysts recommend CME Group a to buy, 7 to hold and 3 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the CME Group a stock has an average upside potential 2027 of . Most analysts recommend the CME Group a stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 11.95 7.09
17.06% 40.65%
EBITDA Margin 83.60% 71.25%
2.24% 14.77%
Net Margin 33.65% 62.67%
1.34% 86.26%

18 Analysts have issued a sales forecast CME Group a 2026 . The average CME Group a sales estimate is

$7.1b
unlock
. This is
43.76% lower
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$7.6b 39.78%
unlock
, the lowest is
$6.8b 46.34%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $12.0b 17.06%
2026
$7.1b 40.65%
unlock
2027
$7.4b 4.99%
unlock
2028
$7.9b 6.46%
unlock
2029
$8.4b 5.59%
unlock
2030
$8.9b 5.85%
unlock

13 Analysts have issued an CME Group a EBITDA forecast 2026. The average CME Group a EBITDA estimate is

$5.1b
unlock
. This is
53.64% lower
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$5.4b 50.11%
unlock
, the lowest is
$4.8b 55.94%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $10.0b 19.69%
2026
$5.1b 49.41%
unlock
2027
$5.3b 4.61%
unlock
2028
$5.7b 7.47%
unlock
2029
$6.3b 10.79%
unlock
2030
$6.7b 6.99%
unlock

EBITDA Margin

2025 83.60% 2.24%
2026
71.25% 14.77%
unlock
2027
71.00% 0.35%
unlock
2028
71.67% 0.94%
unlock
2029
75.20% 4.93%
unlock
2030
76.01% 1.08%
unlock

19 CME Group a Analysts have issued a net profit forecast 2026. The average CME Group a net profit estimate is

$4.4b
unlock
. This is
3.99% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$4.8b 11.38%
unlock
, the lowest is
$4.2b 1.15%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $4.0b 15.50%
2026
$4.4b 10.55%
unlock
2027
$4.7b 5.53%
unlock
2028
$5.0b 7.42%
unlock
2029
$5.5b 8.42%
unlock
2030
$5.8b 6.64%
unlock

Net Margin

2025 33.65% 1.34%
2026
62.67% 86.26%
unlock
2027
62.99% 0.51%
unlock
2028
63.56% 0.90%
unlock
2029
65.27% 2.69%
unlock
2030
65.75% 0.74%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 11.16 12.37
15.41% 10.84%
P/E 21.43
EV/Sales 13.61

19 Analysts have issued a CME Group a forecast for earnings per share. The average CME Group a EPS is

$12.37
unlock
. This is
4.56% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$13.25 12.00%
unlock
, the lowest is
$11.76 0.59%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $11.16 15.41%
2026
$12.37 10.84%
unlock
2027
$13.06 5.58%
unlock
2028
$14.03 7.43%
unlock
2029
$15.21 8.41%
unlock
2030
$16.22 6.64%
unlock

P/E ratio

Current 22.41 14.35%
2026
21.43 4.37%
unlock
2027
20.30 5.27%
unlock
2028
18.90 6.90%
unlock
2029
17.43 7.78%
unlock
2030
16.35 6.20%
unlock

Based on analysts' sales estimates for 2026, the CME Group a stock is valued at an EV/Sales of

13.61
unlock
and an P/S ratio of
13.44
unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 7.65 16.21%
2026
13.61 77.88%
unlock
2027
12.96 4.75%
unlock
2028
12.17 6.07%
unlock
2029
11.53 5.29%
unlock
2030
10.89 5.53%
unlock

P/S ratio

Current 7.56 16.04%
2026
13.44 77.79%
unlock
2027
12.80 4.75%
unlock
2028
12.02 6.07%
unlock
2029
11.39 5.29%
unlock
2030
10.76 5.53%
unlock

Current CME Group a Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
TD Cowen
Locked
➜
Locked
Locked Sep 28 2026
TD Cowen
Locked
➜
Locked
Locked Sep 03 2026
Deutsche Bank
Locked
➜
Locked
Locked Aug 19 2026
JP Morgan
Locked
➜
Locked
Locked Jul 23 2026
B of A Securities
Locked
➜
Locked
Locked Jul 23 2026
Morgan Stanley
Locked
➜
Locked
Locked Jul 23 2026
Piper Sandler
Locked
➜
Locked
Locked Jul 15 2026
Analyst Rating Date
Locked
TD Cowen:
Locked
➜
Locked
Sep 28 2026
Locked
TD Cowen:
Locked
➜
Locked
Sep 03 2026
Locked
Deutsche Bank:
Locked
➜
Locked
Aug 19 2026
Locked
JP Morgan:
Locked
➜
Locked
Jul 23 2026
Locked
B of A Securities:
Locked
➜
Locked
Jul 23 2026
Locked
Morgan Stanley:
Locked
➜
Locked
Jul 23 2026
Locked
Piper Sandler:
Locked
➜
Locked
Jul 15 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today